Compare Kotak Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.45
2.19
NAV
₹15.72
₹44.45
Fund Started
20 Nov 2023
25 Jun 2018
Fund Size
₹496.00 Cr
₹6668.95 Cr
Exit Load
0.5% for redemption within 30 Days
Exit load of 1% if redeemed within 15 days.
1 Year
15.52%
5.68%
3 Year
-
26.25%
5 Year
-
15.27%
Equity
99.02%
96.76%
Cash
0.98%
3.24%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 14.04% |
JB Chemicals & Pharmaceuticals Ltd. | 6.63% |
Max Healthcare Institute Ltd. | 6.31% |
Divi's Laboratories Ltd. | 5.90% |
Fortis Healthcare Ltd. | 4.84% |
Acutaas Chemicals Ltd. | 4.60% |
Cipla Ltd. | 4.22% |
Park Medi World Ltd. | 3.79% |
Krishna Institute of Medical Sciences Ltd | 3.56% |
Apollo Hospitals Enterprise Ltd. | 3.08% |
Sun Pharmaceutical Industries Ltd. | 11.76% |
Cipla Ltd. | 8.15% |
Mankind Pharma Ltd. | 7.58% |
Divi's Laboratories Ltd. | 6.06% |
Dr. Reddy's Laboratories Ltd. | 5.94% |
Biocon Ltd. | 5.81% |
Cohance Lifesciences Ltd. | 4.44% |
Lupin Ltd. | 3.80% |
Medplus Health Services Ltd. | 3.37% |
Alkem Laboratories Ltd. | 3.24% |
Name
-
-
Start Date
-
-
Description
The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
20 Nov 2023
25 Jun 2018
